Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Tristel ( (GB:TSTL) ) has issued an announcement.
Tristel plc announced its successful participation at APIC 2025, the largest annual infection prevention and control conference in the U.S., where it launched Tristel OPH, a high-level disinfectant for ophthalmic instruments, following FDA clearance. The product addresses a significant unmet need in ophthalmology, generating strong interest and establishing a robust pipeline of prospective customers. Tristel also showcased its Tristel ULT disinfectant for ultrasound probes and the Tristel 3T digital traceability platform, both receiving positive reception. This event reinforces Tristel’s momentum in the U.S. market, highlighting the demand for innovative disinfection solutions.
The most recent analyst rating on (GB:TSTL) stock is a Buy with a £4.40 price target. To see the full list of analyst forecasts on Tristel stock, see the GB:TSTL Stock Forecast page.
Spark’s Take on GB:TSTL Stock
According to Spark, TipRanks’ AI Analyst, GB:TSTL is a Outperform.
Tristel’s overall stock score is driven primarily by its strong financial performance and positive corporate events. While the technical analysis shows neutral trends, the company’s strategic moves and high dividend yield offer a balanced outlook. Elevated valuation presents a moderate risk, tempered by positive growth prospects and insider confidence.
To see Spark’s full report on GB:TSTL stock, click here.
More about Tristel
Tristel plc is a global infection prevention company focused on manufacturing and supplying products using its unique proprietary chlorine dioxide chemistry. It is a market leader in manual decontamination of medical devices and provides sporicidal surface disinfection products under the Cache brand. Tristel operates globally, employing approximately 270 people across 16 subsidiaries, selling into over 40 countries. The company is listed on the London Stock Exchange’s AIM market and targets annual revenue growth of 10% to 15% with an EBITDA margin of at least 25%.
Average Trading Volume: 93,828
Technical Sentiment Signal: Buy
Current Market Cap: £194.4M
See more insights into TSTL stock on TipRanks’ Stock Analysis page.